Not Yet RecruitingNot Applicable

Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension

United States168 participantsStarted 2026-07-01

Plain-language summary

The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared with usual care. The main objective is to assess the impact of the CDS tool, that is embedded with the electronic medical record (EMR), that is available during outpatient clinical encounters, on blood pressure (BP) changes among participants with uncontrolled hypertension. Participants will: Visit the clinic 4 weeks, after their initial clinician visit, for a BP check.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Men and women 18 years of age or older
✓. Electronic Health Record (EHR) of hypertension AND prescribed at least one BP lowering medication
✓. Office systolic BP of 130 mmHg or higher
✓. Willing and able to comply with the study instructions AND attend a scheduled study visit

Exclusion criteria

✕. Women who are pregnant, plan to become pregnant, or are breast-feeding
✕. Know heart failure with reduced ejection fraction and a left ventricular ejection fraction of less than 40%
✕. End-stage kidney disease currently undergoing renal replacement therapy, or an eGFR \< 15ml/min/1.73m2
✕. In the opinion of the investigator, any other condition that will preclude participation in the study

What they're measuring

Change in systolic automated office blood pressure (AOBP)

Timeframe: 4 weeks

Trial details

NCT IDNCT07218198

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-07-01

Contact for this trial

Carrie Melgaard, MS

216-318-9094 melgaac@ccf.org

View on ClinicalTrials.gov More Hypertension trials